InternationalFDA Approves First New Schizophrenia Drug In 30 Years: Cobenfy Offers Hope With Fewer Side Effects | DetailsBY Outlook News Desk
‘Serve Like Sachin’: BCCI Wants Vaibhav Sooryavanshi to Avoid Becoming a ‘One-Series or One-Year Wonder’
